Association between TP53 gene Arg72Pro polymorphism and Wilms’ tumor risk in a Chinese population

References

• RiveraMNHaberDAWilms’ tumour: connecting tumorigenesis and organ development in the kidneyNat Rev Cancer20055969971216110318
   PubMed Web of Science ®Google Scholar
• ChuAHeckJERibeiroKBWilms’ tumour: a systematic review of risk factors and meta-analysisPaediatr Perinat Epidemiol201024544946920670226
   PubMed Web of Science ®Google Scholar
• StillerCAParkinDMInternational variations in the incidence of childhood renal tumoursBr J Cancer1990626102610302175212
   PubMed Web of Science ®Google Scholar
• BaoPPLiKWuCXRecent incidences and trends of childhood malignant solid tumors in Shanghai, 2002–2010Zhonghua Er Ke Za Zhi201351428829423927803
   PubMedGoogle Scholar
• ScottRHStillerCAWalkerLRahmanNSyndromes and constitutional chromosomal abnormalities associated with Wilms tumourJ Med Genet200643970571516690728
   PubMed Web of Science ®Google Scholar
• ScottRHDouglasJBaskcombLConstitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumorNat Genet200840111329133418836444
   PubMed Web of Science ®Google Scholar
• LittleSEHanksSPKing-UnderwoodLFrequency and heritability of WT1 mutations in nonsyndromic Wilms’ tumor patients: a UK Children’s Cancer Study Group StudyJ Clin Oncol200422204140414615483024
   PubMedGoogle Scholar
• HarrisCCHollsteinMClinical implications of the p53 tumor-suppressor geneN Engl J Med199332918131813278413413
   PubMed Web of Science ®Google Scholar
• LevineAJp53, the cellular gatekeeper for growth and divisionCell19978833233319039259
   PubMed Web of Science ®Google Scholar
• SagerRTumor suppressor genes: the puzzle and the promiseScience19892464936140614122574499
   PubMed Web of Science ®Google Scholar
• XuHel-GewelyMRP53-responsive genes and the potential for cancer diagnostics and therapeutics developmentBiotechnol Annu Rev2001713116411686042
   PubMedGoogle Scholar
• DumontPLeuJIDella PietraAC3rdGeorgeDLMurphyMThe codon 72 polymorphic variants of p53 have markedly different apoptotic potentialNat Genet200333335736512567188
   PubMed Web of Science ®Google Scholar
• ThomasMKalitaALabrecqueSPimDBanksLMatlashewskiGTwo polymorphic variants of wild-type p53 differ biochemically and biologicallyMol Cell Biol1999192109211009891044
   PubMed Web of Science ®Google Scholar
• SiddiqueMSabapathyKTrp53-dependent DNA-repair is affected by the codon 72 polymorphismOncogene200625253489350016462765
   PubMed Web of Science ®Google Scholar
• WhibleyCPharoahPDHollsteinMp53 polymorphisms: cancer implicationsNat Rev Cancer2009929510719165225
   PubMed Web of Science ®Google Scholar
• KlugSJRessingMKoenigJTP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studiesLancet Oncol200910877278419625214
   PubMed Web of Science ®Google Scholar
• DahabrehIJLinardouHBouzikaPVarvarigouVMurraySTP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysisCancer Epidemiol Biomarkers Prev20101971840184720615891
   PubMed Web of Science ®Google Scholar
• XuTXuZCZouQYuBHuangXEP53 Arg72Pro polymorphism and bladder cancer risk – meta-analysis evidence for a link in Asians but not CaucasiansAsian Pac J Cancer Prev20121352349235422901221
   PubMedGoogle Scholar
• DahabrehIJSchmidCHLauJVarvarigouVMurraySTrikalinosTAGenotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancerAm J Epidemiol2013177121317132523729685
   PubMedGoogle Scholar
• TianXDaiSSunJJiangSJiangYAssociation between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studiesSci Rep201662409727053289
   PubMedGoogle Scholar
• CostNGMituiMKhokharSWickiserJEBakerLARakhejaDTP53 codon 72 polymorphisms in favorable histology Wilms tumorsPediatr Blood Cancer201259232632822052810
   PubMedGoogle Scholar
• AndradeRCCardosoLCFermanSEAssociation of TP53 polymorphisms on the risk of Wilms tumorPediatr Blood Cancer201461343644124038938
   PubMedGoogle Scholar
• FuWZhuJXiongSWBARD1 gene polymorphisms confer nephroblastoma susceptibilityEBioMedicine Epub201713110.1016/j.ebiom.2017.01.038
   Google Scholar
• HeJWangFZhuJAssociation of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese populationJ Cell Mol Med20162081481149027019310
   PubMed Web of Science ®Google Scholar
• HeJYangTZhangRPotentially functional polymorphisms in the LIN28B gene contribute to neuroblastoma susceptibility in Chinese childrenJ Cell Mol Med20162081534154127021521
   PubMed Web of Science ®Google Scholar
• HeJZhangRZouYEvaluation of GWAS-identified SNPs at 6p22 with neuroblastoma susceptibility in a Chinese populationTumour Biol20163721635163926307394
   PubMedGoogle Scholar
• HeJZhongWZengJLMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese populationOncotarget2016716227702277827009839
   PubMedGoogle Scholar
• ZhangRZouYZhuJThe association between GWAS-identified BARD1 gene SNPs and neuroblastoma susceptibility in a Southern Chinese populationInt J Med Sci201613213313826941572
   PubMedGoogle Scholar
• ZhengJZhangRZhuJLack of associations between XPC gene polymorphisms and neuroblastoma susceptibility in a Chinese populationBiomed Res Int20162016293204927847809
   PubMedGoogle Scholar
• HeJQiuLXWangMYPolymorphisms in the XPG gene and risk of gastric cancer in Chinese populationsHum Genet201213171235124422371296
   PubMed Web of Science ®Google Scholar
• BeckwithJBNational Wilms Tumor Study: an update for pathologistsPediatr Dev Pathol199811798410463275
   PubMedGoogle Scholar
• IsobeMEmanuelBSGivolDOrenMCroceCMLocalization of gene for human p53 tumour antigen to band 17p13Nature1986320605784853456488
   PubMed Web of Science ®Google Scholar
• FinlayCAHindsPWLevineAJThe p53 proto-oncogene can act as a suppressor of transformationCell1989577108310932525423
   PubMed Web of Science ®Google Scholar
• ScopinaroMJCasakSJPaediatric oncology in Argentina: medical and ethical issuesLancet Oncol20023211111711902522
   PubMedGoogle Scholar
• PetitjeanAAchatzMIBorresen-DaleALHainautPOlivierMTP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomesOncogene200726152157216517401424
   PubMed Web of Science ®Google Scholar
• FrebourgTFriendSHCancer risks from germline p53 mutationsJ Clin Invest1992905163716411430194
   PubMedGoogle Scholar
• WangYWuXSHeJMaTLeiWShenZYA novel TP53 variant (rs78378222 A > C) in the polyadenylation signal is associated with increased cancer susceptibility: evidence from a meta-analysisOncotarget2016722328543286527147571
   PubMedGoogle Scholar
• MatlashewskiGJTuckSPimDLambPSchneiderJCrawfordLVPrimary structure polymorphism at amino acid residue 72 of human p53Mol Cell Biol1987729619633547088
   PubMed Web of Science ®Google Scholar
• MarinMCJostCABrooksLAA common polymorphism acts as an intragenic modifier of mutant p53 behaviourNat Genet2000251475410802655
   PubMed Web of Science ®Google Scholar
• StoreyAThomasMKalitaARole of a p53 polymorphism in the development of human papillomavirus-associated cancerNature199839366822292349607760
   PubMed Web of Science ®Google Scholar